Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer
Feng Ye, Saikat Dewanjee, Yuehua Li, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 267

Showing 26-50 of 267 citing articles:

A fractional-order model for optimizing combination therapy in heterogeneous lung cancer: integrating immunotherapy and targeted therapy to minimize side effects
David Amilo, Chinedu Izuchukwu, Khadijeh Sadri, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Identification and characterization of CLEC11A and its derived immune signature in gastric cancer
Qing Yin Zheng, Zhenqi Gong, Baizhi Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Regulatory and therapeutic implications of competing endogenous RNA network in breast cancer progression and metastasis: A review
I. Saranya, V. Sowfika Dharshini, R.L. Akshaya, et al.
International Journal of Biological Macromolecules (2024) Vol. 266, pp. 131075-131075
Closed Access | Times Cited: 6
Bioinspired ginsenoside Rg3 PLGA nanoparticles coated with tumor-derived microvesicles to improve chemotherapy efficacy and alleviate toxicity
Shulei Zhang, Zheng Bo, Yiqi Wei, et al.
Biomaterials Science (2024) Vol. 12, Iss. 10, pp. 2672-2688
Closed Access | Times Cited: 6
Potential therapeutic targets of the JAK2/STAT3 signaling pathway in triple-negative breast cancer
Long Lin, Xiangyu Fei, Liucui Chen, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 6
Molecular targeted therapies for cutaneous squamous cell carcinoma: recent developments and clinical implications.
H. B. Singh, Hitesh Chopra, Inderbir Singh, et al.
PubMed (2024) Vol. 23, pp. 300-334
Closed Access | Times Cited: 6
A Review of the Advancements in Targeted Therapies for Breast Cancer
John Kessellie Jallah, Tuward J. Dweh, Ashish Anjankar, et al.
Cureus (2023)
Open Access | Times Cited: 15
AURKAIP1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancer
W. H. Tian, Yuhui Tang, Yongzhou Luo, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 12
Open Access | Times Cited: 15
VISTA: a novel checkpoint for cancer immunotherapy
Yu Gao, Yanting He, Yuanyuan Tang, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 104045-104045
Closed Access | Times Cited: 5
Herb pair of Huangqi‐Danggui exerts anti‐tumor immunity to breast cancer by upregulating PIK3R1
Hai‐Xin Liu, Lian Li, Lili Hou, et al.
Animal Models and Experimental Medicine (2024) Vol. 7, Iss. 3, pp. 234-258
Open Access | Times Cited: 5
mRNA‐Lipid Nanoparticle‐Mediated Restoration of PTPN14 Exhibits Antitumor Effects by Overcoming Anoikis Resistance in Triple‐Negative Breast Cancer
Wei Li, Masha Huang, Zhaoping Wu, et al.
Advanced Science (2024) Vol. 11, Iss. 32
Open Access | Times Cited: 5
Advances in Personalized Oncology
Hiba Mechahougui, James Gutmans, Gina Colarusso, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2862-2862
Open Access | Times Cited: 5
Recent Advances in Immunotherapy for Breast Cancer: A Review
Qian-Er Wen, Liang Li, Rui-Qi Feng, et al.
Breast Cancer Targets and Therapy (2024) Vol. Volume 16, pp. 497-516
Open Access | Times Cited: 5
Recognition of MCF-7 breast cancer cells using native collagen probes: Collagen source effect
Benmei Wei, Siying Huang, Ké Li, et al.
International Journal of Biological Macromolecules (2024), pp. 136661-136661
Closed Access | Times Cited: 5
One-pot preparation of pH- and redox-responsive polymeric microgel as an efficient carrier for improved breast cancer therapy
Di Huang, Jing Zhu, Mengfan Xu, et al.
Colloids and Surfaces A Physicochemical and Engineering Aspects (2024) Vol. 685, pp. 133320-133320
Closed Access | Times Cited: 4
Expression and Clinical Significance of NUDCD1, PI3K/AKT/mTOR Signaling Pathway-Related Molecules and Immune Infiltration in Breast Cancer
Wei Wen, Yuehua Li, Xi Cao, et al.
Clinical Breast Cancer (2024) Vol. 24, Iss. 6, pp. e429-e451
Open Access | Times Cited: 4
Nucleic acid vaccines‐based therapy for triple‐negative breast cancer: A new paradigm in tumor immunotherapy arena
Raed Obaid Saleh, Fatma M. Ibrahim, Harikumar Pallathadka, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 3
Closed Access | Times Cited: 4
Circ_0001786 facilitates gefitinib resistance and malignant progression in non-small cell lung cancer via miR-34b-5p/SRSF1
Kaobin Ouyang, Dan Xie, Haojie Liao, et al.
Journal of Cardiothoracic Surgery (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 4
Immunotherapy for Brain Tumors: Where We Have Been, and Where Do We Go From Here?
Alexander F. Wang, Brian Hsueh, Bryan D. Choi, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 5, pp. 628-643
Closed Access | Times Cited: 4
Establishment of a novel microfluidic co-culture system for simultaneous analysis of multiple indicators of gefitinib sensitivity in colorectal cancer cells
Xin Li, Wanming Li, Jie Wang, et al.
Microchimica Acta (2024) Vol. 191, Iss. 5
Closed Access | Times Cited: 4
Application of immune checkpoint inhibitors for resectable gastric/gastroesophageal cancer
Feizhi Lin, Yongming Chen, Bowen Huang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Exploring Disulfiram’s Anticancer Potential: PLGA Nano-Carriers for Prolonged Drug Delivery and Potential Improved Therapeutic Efficacy
Ibrahim Dumbuya, Ana Maria Pereira, Ibrahim Tolaymat, et al.
Nanomaterials (2024) Vol. 14, Iss. 13, pp. 1133-1133
Open Access | Times Cited: 4
Exosomal circ‐0100519 promotes breast cancer progression via inducing M2 macrophage polarisation by USP7/NRF2 axis
Minyu Zhuang, Xiaoqiang Zhang, Jie Ji, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 8
Open Access | Times Cited: 4
In silico evaluation of potential breast cancer receptor antagonists from GC-MS and HPLC identified compounds in Pleurotus ostreatus extracts
Magdalene Eno Effiong, Mercy Bella-Omunagbe, Israel Sunmola Afolabi, et al.
RSC Advances (2024) Vol. 14, Iss. 33, pp. 23744-23771
Open Access | Times Cited: 4
The YTH domain‐containing protein family: Emerging players in immunomodulation and tumour immunotherapy targets
Fenghe Li, Chong Zeng, Jie Liu, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 8
Open Access | Times Cited: 4

Scroll to top